" class="no-js "lang="en-US"> Reshema Kemps-Polanco - Medtech Alert
Tuesday, October 14, 2025
Reshema Kemps-Polanco

Reshema Kemps-Polanco

About Reshema Kemps-Polanco

Reshema Kemps-Polanco is Executive Vice President, US Oncology.  In this role she is responsible for all commercial and medical operations covering the United States.

Most recently, Reshema served as President, Cardiovascular & Metabolism (CVM), US, and President, Janssen Pharmaceuticals, Puerto Rico.

Before joining CVM, Reshema served as Vice President, Solid Tumor Sales & Marketing in the US Oncology business where she led the expansion of Janssen Oncology’s solid tumor portfolio, with a focus on genitourinary oncology. Reshema previously held multiple leadership roles within the Global Commercial Strategy Organization, helping ensure the long-term sustainability for their prostate cancer business.

Prior to Janssen, Reshema spent 15 years at Novartis where she led multiple marketing teams within Oncology and General Medicines. She also served as Assistant to the CEO and Head of North America at Novartis and held other commercial roles of increasing responsibility across multiple therapeutic areas.

Reshema was recognized by the Healthcare Businesswomen’s Association (HBA) as a Rising Star and a Top-40-Under-40-Achiever by The Network Journal during her tenure at Novartis.

Reshema is a purpose driven leader with a strong track record of building diverse, inclusive, high-performing teams, as well as leading through adversity and ambiguity. She is inspired by improving healthcare outcomes through therapies and services that deliver advancements in the standard of care, creating equal access to medicines, and decreasing healthcare inequities. Reshema embraces the organization’s curious, inspired and unbossed culture that will enable the team to drive the Novartis mission to reimagine medicine.

In addition to Reshema’s commercial accomplishments, she is a strong believer in servant leadership and a passionate developer and sponsor of talent.

Reshema earned a Master’s in Business Administration from Rutgers University, holds a Master’s Degree in Industrial/Organizational Behavior from Louisiana Tech University, and a Bachelor’s Degree from the University of Louisiana at Monroe. She also proudly served her country as a member of the U.S. Army.

Related Story

New Novartis Data Show Piqray® Effectiveness Across Key Biomarkers in Patients With HR+/HER2- Metastatic Breast Cancer

June 6 2022

Novartis today announced results of an exploratory retrospective biomarker analysis finding that different genetic mutation […]